Germany: SPCs for medical devices
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Germany: SPCs for medical devices

While SPCs can be granted for medicinal products in accordance with Regulation (EC) No 469/2009, it has been questioned whether medical devices that are also subject to a lengthy product approval process similar to medicinal products could be eligible for SPC protection in the absence of an explicit Regulation in this respect. In the past, the German Federal Patent Court (Bundespatentgericht or BPatG) adopted a relatively liberal approach in deciding that SPCs for an implantable medical device comprising a pharmaceutically active substance are allowable (14 W (pat) 12/07). A recent case may signal that the German Federal Patent Court may apply a stricter approach in the future.

The 14th Senate of the BPatG held in decision 14 W (pat) 45/12 that SPCs cannot be granted for medical devices under the Regulation and the corresponding case law of the CJEU. The Leibniz-Institut für Neue Materialien gGmbH filed an SPC application for aminosilane-coated iron oxide nanoparticles, which are directly introduced into a tumour and then heated by the application of an external magnetic field. This treatment results in the destruction or in the sensitisation of the tumour cells for further treatment. The application was based on an EC design-examination certificate in accordance with Directive 93/42/EEC on Medical Devices.

According to Article 1(b) of the Regulation, "product" means the active ingredient or combination of active ingredients of a medicinal product. Since the term "active ingredient" is not defined in the Regulation, the BPatG referred to the CJEU decision Forsgren (C-631/13), which held that active ingredients must have pharmacological, immunological or metabolic action of their own. The BPatG concluded that the therapeutic effect of the aminosilane-coated iron oxide particles, which are inactive on their own, is purely physical, and therefore the particles do not fall under the definition of the term "product" as defined by Article 1(b) of the Regulation, thus ruling out the application of the Regulation.

While the BPatG indicated that it favours the grant of SPCs for medical products, it made clear that it will be up to the legislator to implement corresponding legal frameworks. It remains to be seen whether the recent decision marks a new era of stricter rulings on SPCs to medical devices in Germany, or whether it only precludes the grant of SPCs for medical devices that do not have a therapeutic effect on their own.

Wunsche

Annelie Wünsche


Maiwald Patentanwalts GmbHElisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64 24info@maiwald.euwww.maiwald.eu

more from across site and ros bottom lb

More from across our site

In-house lawyers reveal how they balance cost, quality, and other criteria to get the most from their relationships with external counsel
Dario Pietrantonio of Robic discusses growth opportunities for the firm and shares insights from his journey to managing director
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Law firms that pay close attention to their client relationships are more likely to win repeat work, according to a survey of nearly 29,000 in-house counsel
The EMEA research period is open until May 31
Practitioners analyse a survey on how law firms prove value to their clients and reflect on why the concept can be hard to pin down
The winner of Managing IP’s Life Achievement Award discusses 50 years in IP law and how even he can’t avoid imposter syndrome
Saya Choudhary of Singh & Singh explains how her team navigated nine years of litigation to secure record damages of $29 million and the lessons learned along the way
The full list of finalists has been revealed and the winners will be presented on June 20 at the Metropolitan Club in New York
A team of IP and media law specialists has joined from SKW Schwarz alongside a former counsel at Sky
Gift this article